Dr. Karin S. Goodfriend, MD
Physical Medicine & Rehabilitation (PM&R) (Physical Medicine & Rehabilitation Physician)
9200 W Wisconsin Ave, Physical Medicine And Rehabilitation
Milwaukee, WI 53226
Who else practices at this address →
Milwaukee County includes primary care (32% of residents) and mental health (34% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Wayne State University School of Medicine (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 27
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: Wayne State University School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Physical Medicine & Rehabilitation Physician primary
WI license 56811 -
Pediatric Rehabilitation Medicine Physician
WI license 56811
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Physical Medicine & Rehabilitation (PM&R) per capita by county →
Where they work
Hospitals
- Froedtert Memorial Lutheran Hospital Milwaukee, WI
Medical groups
- The Medical College of Wisconsin Inc (2,115 clinicians)
- Childrens Specialty Group Inc (198 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 27
- Services billed
- 148
- Patients’ average age
- 56
| Service | Times | Patients |
|---|---|---|
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 50 | 21 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 37 | 13 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 26 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Baclofen Other prescribers in Milwaukee, WI | 59 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 33 payments worth $42,755 in total to this clinician.
| Ipsen Biopharmaceuticals, Inc | $42,164 |
|---|---|
| Pacira Pharmaceuticals Incorporated | $415 |
| Merz Pharmaceuticals, LLC | $111 |
| AbbVie Inc. | $49.77 |
| Piramal Critical Care | $14.79 |
| Compensation for services other than consulting (speaking, faculty) | $34,790 |
|---|---|
| Travel and Lodging | $5,731 |
| Food and Beverage | $2,234 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc Sep 6, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $7,100 |
| Ipsen Biopharmaceuticals, Inc Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $6,035 |
| Ipsen Biopharmaceuticals, Inc Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $5,680 |
| Ipsen Biopharmaceuticals, Inc May 10, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $5,680 |
| Ipsen Biopharmaceuticals, Inc Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $4,615 |
| Ipsen Biopharmaceuticals, Inc Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $4,615 |
| Ipsen Biopharmaceuticals, Inc Sep 6, 2025 | Travel and Lodging Dysport · Neurology · travel to La Jolla, CA · in-kind | $1,288 |
| Ipsen Biopharmaceuticals, Inc Jul 23, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $1,065 |
| Ipsen Biopharmaceuticals, Inc May 10, 2025 | Travel and Lodging Dysport · Neurology · travel to Philadelphia, PA · in-kind | $865 |
| Ipsen Biopharmaceuticals, Inc Oct 30, 2025 | Travel and Lodging Dysport · Neurology · travel to Alburquerqe, NM · in-kind | $807 |
All 18 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $5,680 |
| Ipsen Biopharmaceuticals, Inc Oct 30, 2025 | Travel and Lodging Dysport · Neurology · travel to Alburquerqe, NM · in-kind | $807 |
| Ipsen Biopharmaceuticals, Inc Oct 30, 2025 | Travel and Lodging Dysport · Neurology · travel to Alburquerqe, NM · in-kind | $334 |
| Ipsen Biopharmaceuticals, Inc Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $6,035 |
| Ipsen Biopharmaceuticals, Inc Sep 6, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $7,100 |
| Ipsen Biopharmaceuticals, Inc Sep 6, 2025 | Travel and Lodging Dysport · Neurology · travel to La Jolla, CA · in-kind | $1,288 |
| Ipsen Biopharmaceuticals, Inc Sep 6, 2025 | Travel and Lodging Dysport · Neurology · travel to La Jolla, CA · in-kind | $325 |
| Ipsen Biopharmaceuticals, Inc Jul 23, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $1,065 |
| Ipsen Biopharmaceuticals, Inc May 10, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $5,680 |
| Ipsen Biopharmaceuticals, Inc May 10, 2025 | Travel and Lodging Dysport · Neurology · travel to Philadelphia, PA · in-kind | $865 |
| Ipsen Biopharmaceuticals, Inc May 10, 2025 | Travel and Lodging Dysport · Neurology · travel to Philadelphia, PA · in-kind | $383 |
| Ipsen Biopharmaceuticals, Inc Apr 17, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $4,615 |
| Ipsen Biopharmaceuticals, Inc Apr 17, 2025 | Travel and Lodging Dysport · Neurology · travel to Mishawaka, IN · in-kind | $290 |
| Ipsen Biopharmaceuticals, Inc Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $4,615 |
| Ipsen Biopharmaceuticals, Inc Mar 6, 2025 | Travel and Lodging Dysport · Neurology · travel to Murrysville, PA · in-kind | $456 |
| Ipsen Biopharmaceuticals, Inc Mar 6, 2025 | Travel and Lodging Dysport · Neurology · travel to Murrysville, PA · in-kind | $421 |
| Ipsen Biopharmaceuticals, Inc Mar 6, 2025 | Travel and Lodging Dysport · Neurology · travel to Murrysville, PA · in-kind | $170 |
| Ipsen Biopharmaceuticals, Inc Feb 7, 2025 | Travel and Lodging Dysport · Neurology · travel to Washington, DC · in-kind | $392 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $33,077 in research payments for these studies, mostly to the institutions running them.
- A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
Ipsen Pharma Sas · Completed · NCT04936542 - A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of iovera®° system in Subjects with Upper Extremity Spasticity
Pacira Pharmaceuticals Incorporated
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.